Annotations: 6LUI

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	PF21524	e6luiA1	A: alpha arrays	X: HTH	H: HTH	T: winged	F: PF21524	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF21524	SAM domain-containing protein 1, WH domain (SAMD1_WH)	SAM domain-containing protein 1, WH domain	SAM domain-containing protein 1 (SAMD1, also known as Atherin) is an unmethylated CpG island (CGI)-binding protein that acts as a repressive chromatin regulator. It consists of a C-terminal SAM domain (Pfam:PF00536), a central unstructured region and ...	SAM domain-containing protein 1 (SAMD1, also known as Atherin) is an unmethylated CpG island (CGI)-binding protein that acts as a repressive chromatin regulator. It consists of a C-terminal SAM domain (Pfam:PF00536), a central unstructured region and an atypical winged-helix N-terminal domain that directly recognizes unmethylated CpG-containing DNA. This domain has also been found in the transcriptional regulators KAT6A, KAT6B, and ZMYND11 which were grouped together as a novel class of WH domains. This entry represents this novel group of WH domains [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Atherin	DNA binding binding organic cyclic compound binding nucleic acid binding lipoprotein particle binding protein-containing complex binding protein-lipid complex binding low-density lipoprotein particle binding chromatin binding	developmental process foam cell differentiation cellular developmental process cell differentiation cellular process regulation of cellular component organization regulation of cellular process cellular biosynthetic process negative regulation of biological process negative regulation of cellular metabolic process protein-DNA complex organization cellular component organization organic substance metabolic process chromatin organization developmental process foam cell differentiation cellular developmental process cell differentiation cellular process regulation of cellular component organization regulation of cellular process cellular biosynthetic process negative regulation of biological process negative regulation of cellular metabolic process protein-DNA complex organization cellular component organization organic substance metabolic process chromatin organization organic substance biosynthetic process negative regulation of cellular process DNA methylation-dependent heterochromatin formation chromatin remodeling cellular component organization or biogenesis regulation of heterochromatin formation negative regulation of macromolecule metabolic process regulation of biosynthetic process regulation of biological process regulation of chromatin organization heterochromatin formation protein-containing complex organization regulation of DNA methylation-dependent heterochromatin formation epigenetic regulation of gene expression cellular metabolic process negative regulation of metabolic process biological regulation regulation of cellular metabolic process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process negative regulation of cellular biosynthetic process regulation of cellular biosynthetic process regulation of gene expression negative regulation of gene expression biosynthetic process negative regulation of biosynthetic process negative regulation of macromolecule biosynthetic process negative regulation of gene expression, epigenetic regulation of macromolecule biosynthetic process metabolic process facultative heterochromatin formation macromolecule metabolic process regulation of metabolic process lipoprotein modification organonitrogen compound metabolic process lipoprotein metabolic process primary metabolic process lipid modification lipoprotein oxidation cellular lipid metabolic process protein metabolic process lipid oxidation lipoprotein lipid oxidation lipid metabolic process regulation of primary metabolic process negative regulation of RNA biosynthetic process nucleobase-containing compound metabolic process DNA-templated transcription regulation of RNA metabolic process transcription by RNA polymerase II negative regulation of nucleobase-containing compound metabolic process regulation of nucleobase-containing compound metabolic process regulation of transcription by RNA polymerase II negative regulation of DNA-templated transcription negative regulation of transcription by RNA polymerase II organic cyclic compound metabolic process organic cyclic compound biosynthetic process regulation of DNA-templated transcription negative regulation of RNA metabolic process RNA metabolic process RNA biosynthetic process nucleic acid biosynthetic process regulation of RNA biosynthetic process nucleobase-containing compound biosynthetic process nucleic acid metabolic process cellular component biogenesis cellular component assembly protein complex oligomerization protein-containing complex assembly protein homooligomerization	intracellular organelle intracellular anatomical structure organelle intracellular non-membrane-bounded organelle chromosome cellular anatomical entity non-membrane-bounded organelle extracellular region extracellular space membrane-bounded organelle nucleus intracellular membrane-bounded organelle
B	DNA (5'-D(APCPCPTPGPCPGPCPAPCPCPAP*T)-3')	-	-	-
C	DNA (5'-D(APTPGPGPTPGPCPGPCPAPGPGP*T)-3')	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR013761	Sterile alpha motif/pointed domain superfamily	Homologous Superfamily
A	IPR048589	SAM domain-containing protein 1-like, WH domain	Domain
A	IPR001660	Sterile alpha motif domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q6SPF0	atypical teratoid rhabdoid tumor medulloblastoma glioblastoma primitive neuroectodermal tumor large cell medulloblastoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.